Publication | Open Access
Social and Biological Determinants in Lung Cancer Disparity
24
Citations
77
References
2024
Year
Health Care DisparityEpidemiology Of CancerHealth DisparitiesSocial Determinants Of HealthRacial DisparitiesUnited StatesCancer DisparityRaceTobacco ControlOncologyAfrican American StudiesPublic HealthRacismSmoking Related Lung DiseaseCancer ResearchLung Cancer DisparityHealth EquityLung CancerCancer EpidemiologyBronchial NeoplasmMedicineHealth Disparity
Lung cancer remains a leading cause of death in the United States and globally, despite progress in treatment and screening efforts. While mortality rates have decreased in recent years, long-term survival of patients with lung cancer continues to be a challenge. Notably, African American (AA) men experience significant disparities in lung cancer compared to European Americans (EA) in terms of incidence, treatment, and survival. Previous studies have explored factors such as smoking patterns and complex social determinants, including socioeconomic status, personal beliefs, and systemic racism, indicating their role in these disparities. In addition to social factors, emerging evidence points to variations in tumor biology, immunity, and comorbid conditions contributing to racial disparities in this disease. This review emphasizes differences in smoking patterns, screening, and early detection and the intricate interplay of social, biological, and environmental conditions that make African Americans more susceptible to developing lung cancer and experiencing poorer outcomes.
| Year | Citations | |
|---|---|---|
2022 | 17.9K | |
2023 | 16.1K | |
2022 | 3.6K | |
2011 | 2.6K | |
2005 | 2.4K | |
2005 | 2.2K | |
2020 | 1.7K | |
2010 | 1.2K | |
2016 | 1.1K | |
Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling Gregory E. Miller, Edith Chen, Alexandra Fok, Proceedings of the National Academy of Sciences GeneticsGenetic EpidemiologyNeuroendocrinologyImmunologyDecreased Glucocorticoid | 2009 | 806 |
Page 1
Page 1